Rhythm Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Rhythm Biosciences has a total shareholder equity of A$867.2K and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$1.5M and A$651.5K respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$754.50k |
| Equity | AU$867.17k |
| Total liabilities | AU$651.54k |
| Total assets | AU$1.52m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0RY's short term assets (A$886.7K) exceed its short term liabilities (A$561.8K).
Long Term Liabilities: 0RY's short term assets (A$886.7K) exceed its long term liabilities (A$89.7K).
Debt to Equity History and Analysis
Debt Level: 0RY is debt free.
Reducing Debt: 0RY had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0RY has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0RY has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.7% each year